Business ❯ Pharmaceutical Industry

Drug Pricing

Market Competition Market Access Market Trends Market Dynamics Market Regulation Market Strategies Market Launch Insurance Coverage Market Impact Healthcare Costs

ICIJ Investigation Details How Merck Kept Keytruda Prices High

Investigators describe access barriers tied to pricing tactics, patent shields, dosing choices, influence payments.

Lilly Urges Recall After Finding New Impurity in Compounded Tirzepatide With B12

Brazil Nears Semaglutide Patent Expiry as Anvisa Reviews 14 Filings and Novo Nordisk Counters

UK Puts Aspirin on Export Ban as Pharmacies Report 75mg Shortage

Mexico Studies Plan to Cut Drug Prices Through Talks, Not Caps

Brazil’s Chamber Fast-Tracks Bill to Enable Compulsory Licensing of Tirzepatide Drugs

Trump Launches TrumpRx.gov With Discounts on More Than 40 Medicines, Including GLP-1 Drugs

India Waives Customs Duty on 17 Cancer Drugs and 7 Rare-Disease Therapies

Delhi High Court Allows Zydus to Market Nivolumab Biosimilar on Public‑Interest Grounds

Amazon Pharmacy Adds FDA-Approved Wegovy Pill With $25 Copays and Nationwide Delivery

BMJ Review Finds Rapid Weight Regain After Stopping GLP-1 Weight-Loss Injections

Canada Opens Path to Generic Ozempic as Health Canada Weighs Nine Applications

White House Adds 9 Pharma Deals, Extending Drug-Price Pacts to 14 Manufacturers

LDP and Ishin Agree to Keep Coverage for OTC‑Like Drugs With 25% 'Special Fee'

Germany Widens Crackdown on Forged Prescription Rings as Fraud Shifts to Costly Cancer Drugs

India Approves Donanemab for Early Alzheimer’s as Lilly Targets 2026 Launch

Novo Nordisk Slashes Wegovy Price in India by Up to 37% to Take On Mounjaro

White House Finalizes GLP-1 Price Deal With Lilly and Novo, Setting $50 Medicare Copays

White House Strikes Deals With Lilly and Novo to Cut GLP-1 Prices, Widen Medicare Access

Man Collapses in Oval Office During Trump Drug-Price Announcement